Otahal, Alexander
Kuten-Pella, Olga
Kramer, Karina
Neubauer, Markus
Lacza, Zsombor
Nehrer, Stefan
De Luna, Andrea
Funding for this research was provided by:
European Fund for Regional Development (EFRE) and the Fund for Economy and Tourism of Lower Austria (WST3-F-5030664/003-2017)
Article History
Received: 9 November 2020
Accepted: 11 February 2021
First Online: 12 March 2021
Competing interests
: Z.L. is CEO and O.K.-P. is employee of Orthosera GmbH developing the hypACT inject device. The other authors declare no competing interest.